abstract |
FIELD: pharmaceutical industry. SUBSTANCE: present invention describes novel compounds of formula I: $$$ wherein X, $$$ are as defined in the specification. Said compounds inhibit activity of angiotensine II and are therefore useful as antihypertonic agents. Formula I is given in the specification. EFFECT: improved properties of the title compounds. 22 cl, 2 tbl |